"The contract is a cost-plus monthly reimbursement arrangement. PolyNovo will continue to contribute to the trial through the provision of product, employee resources and infrastructure support." so, the way I read it, they are incurring a small loss on products supplied to BARDA. Well worth it in the long run assuming it's a success though.
"The contract is a cost-plus monthly reimbursement arrangement....
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.08 |
Change
0.050(2.46%) |
Mkt cap ! $1.435B | |||
| Open | High | Low | Value | Volume |
| $2.01 | $2.09 | $2.01 | $3.563M | 1.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3195 | $2.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.09 | 12574 | 3 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.07 |
Change
0.050 ( 1.95 %) |
||||
| Open | High | Low | Volume | ||
| $2.01 | $2.09 | $2.01 | 315933 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| PNV (ASX) Chart |